These findings suggest that miR-145-5p may suppress UTUC cell motility and invasion by targeting ARF6/MMP7 through the epithelial–mesenchymal transition [208]. This evidence concerns the gene ARF6 and renal pelvis/ureter urothelial carcinoma.